| The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception MW Weiner, DP Veitch, PS Aisen, LA Beckett, NJ Cairns, RC Green, ... Alzheimer's & Dementia 9 (5), e111-e194, 2013 | 964 | 2013 |
| The Alzheimer's disease neuroimaging initiative: progress report and future plans MW Weiner, PS Aisen, CR Jack Jr, WJ Jagust, JQ Trojanowski, L Shaw, ... Alzheimer's & Dementia 6 (3), 202-211. e7, 2010 | 504 | 2010 |
| Reduced reward learning predicts outcome in major depressive disorder E Vrieze, DA Pizzagalli, K Demyttenaere, T Hompes, P Sienaert, ... Biological psychiatry 73 (7), 639-645, 2013 | 457 | 2013 |
| Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers SM Landau, BA Thomas, L Thurfjell, M Schmidt, R Margolin, M Mintun, ... European journal of nuclear medicine and molecular imaging 41, 1398-1407, 2014 | 294 | 2014 |
| Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of 11C-labeled 2 … AA Wilson, N Ginovart, M Schmidt, JH Meyer, PG Threlkeld, S Houle Journal of medicinal chemistry 43 (16), 3103-3110, 2000 | 285 | 2000 |
| Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688 SM Ametamey, V Treyer, J Streffer, MT Wyss, M Schmidt, M Blagoev, ... Journal of Nuclear Medicine 48 (2), 247-252, 2007 | 206 | 2007 |
| Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials E Liu, ME Schmidt, R Margolin, R Sperling, R Koeppe, NS Mason, ... Neurology 85 (8), 692-700, 2015 | 169 | 2015 |
| Dimensions in major depressive disorder and their relevance for treatment outcome E Vrieze, K Demyttenaere, R Bruffaerts, D Hermans, DA Pizzagalli, ... Journal of affective disorders 155, 35-41, 2014 | 148 | 2014 |
| A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials L Sforzini, C Worrell, M Kose, IM Anderson, B Aouizerate, V Arolt, M Bauer, ... Molecular psychiatry 27 (3), 1286-1299, 2022 | 138 | 2022 |
| Urinary free cortisol output and disruptive behavior in children MJP Kruesi, ME Schmidt, M Donnelly, ED Hibbs, SD Hamburger Journal of the American Academy of Child & Adolescent Psychiatry 28 (3), 441-443, 1989 | 125 | 1989 |
| The influence of biological and technical factors on quantitative analysis of amyloid PET: points to consider and recommendations for controlling variability in longitudinal data ME Schmidt, P Chiao, G Klein, D Matthews, L Thurfjell, PE Cole, ... Alzheimer's & Dementia 11 (9), 1050-1068, 2015 | 123 | 2015 |
| The effects of ECT on brain glucose: a pilot FDG PET study ME Henry, ME Schmidt, JA Matochik, EP Stoddard, WZ Potter The journal of ECT 17 (1), 33-40, 2001 | 102 | 2001 |
| A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: a 19-F MRS study ME Henry, ME Schmidt, J Hennen, RA Villafuerte, ML Butman, P Tran, ... Neuropsychopharmacology 30 (8), 1576-1583, 2005 | 95 | 2005 |
| The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder ME Schmidt, M Fava, JM Robinson, R Judge Journal of Clinical Psychiatry 61 (11), 851-857, 2000 | 90 | 2000 |
| PET imaging shows loss of striatal PDE10A in patients with Huntington disease R Ahmad, S Bourgeois, A Postnov, ME Schmidt, G Bormans, K Van Laere, ... Neurology 82 (3), 279-281, 2014 | 89 | 2014 |
| High levels of Gs alpha in platelets of euthymic patients with bipolar affective disorder PB Mitchell, HK Manji, G Chen, L Jolkovsky, E Smith-Jackson, K Denicoff, ... Am J Psychiatry 154 (2), 218-23, 1997 | 85 | 1997 |
| Preclinical evaluation of a P2X7 receptor–selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in nonhuman primates D Ory, S Celen, R Gijsbers, C Van Den Haute, A Postnov, M Koole, ... Journal of Nuclear Medicine 57 (9), 1436-1441, 2016 | 84 | 2016 |
| Preclinical evaluation of 18F-JNJ64349311, a novel PET tracer for tau imaging L Declercq, F Rombouts, M Koole, K Fierens, J Mariën, X Langlois, ... Journal of nuclear medicine 58 (6), 975-981, 2017 | 77 | 2017 |
| Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods V Treyer, J Streffer, MT Wyss, A Bettio, SM Ametamey, U Fischer, ... Journal of nuclear medicine 48 (7), 1207-1215, 2007 | 72 | 2007 |
| Treatment Approaches to Major Depressive Disorder RelapsePart 1: Dose Increase ME Schmidt, M Fava, S Zhang, J Gonzales, NJ Raute, R Judge Psychotherapy and Psychosomatics 71 (4), 190-194, 2002 | 72 | 2002 |
